Masimo Co. has a 52 week low of $101.61 and a 52 week high of $180.97. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Want More Great Investing ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.

Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after longtime CEO and founder Joe Kiani was ousted in a bitter proxy battle with ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE, Calif., January 21, 2025--(BUSINESS WIRE)--Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading ...

(This Jan. 21 story has been corrected to fix the share price gain to 57% from 45% in paragraph 6) (Reuters) - Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie ...

Masimo Corporation MASI announced preliminary revenues for the fourth quarter and full year 2024 on Thursday. Following the robust preliminary results, the company’s shares gained nearly 0.1% ...

Masimo (MASI) announced that Katie Szyman has been appointed the next Chief Executive Officer of the Company. Interim CEO Michelle Brennan has been appointed Chairman of Masimo’s Board and Lead ...